遗传风险是否改变皮肤筛查对黑色素瘤检出率的影响
黑色素瘤发病率随PGS三分位升高(ASR每10万人年:三分位1=442;三分位2=519;三分位3=871)。皮肤检查与黑色素瘤检出风险在各PGS三分位间的HR差异无统计学意义,遗传风险不能解释筛查者与未筛查者间的检出率差异。
要点
- 黑色素瘤年龄标化发病率随PGS三分位升高:三分位1=442、三分位2=519、三分位3=871(每10万人年)。
- 皮肤检查与黑色素瘤检出的HR在各PGS三分位间差异无统计学意义。
- 遗传风险不能解释筛查者与未筛查者之间黑色素瘤检出率的差异。
核心结论
- 遗传风险可预测后续黑色素瘤发病率,且与筛查行为弱相关,但不能解释筛查者与未筛查者间较高的黑色素瘤检出率。
主要发现
- 黑色素瘤年龄标化发病率随PGS三分位升高(每10万人年):三分位1=442;三分位2=519;三分位3=871。
- 皮肤检查与全部黑色素瘤(原位和侵袭性)的HR在各PGS三分位间略有差异但无统计学意义:年龄和性别调整后三分位1 HR 1.88(95% CI 1.26-2.81)、三分位2 HR 1.70(95% CI 1.20-2.41)、三分位3 HR 1.96(95% CI 1.43-2.70);完全调整后三分位1 HR 1.14(95% CI 0.74-1.75)、三分位2 HR 1.21(95% CI 0.82-1.78)、三分位3 HR 1.41(95% CI 1.00-1.98)。
- 皮肤检查与原位黑色素瘤的HR在各PGS三分位间相似。
- 侵袭性黑色素瘤的HR点估计在PGS三分位3最高(最小调整和完全调整模型),但差异无统计学意义。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Skin screening is associated with higher melanoma detection rates, a potential indicator of overdiagnosis, but it remains possible that this effect is due to confounding by genetic risk. OBJECTIVES: To compare melanoma incidence among screened vs. unscreened participants within tertiles of genetic risk. METHODS: We investigated melanoma incidence in the QSkin study, a prospective cohort study which for this analysis comprised 15 283 participants aged 40-69 years with genotype data and no prior history of melanoma. We calculated a polygenic score (PGS) for melanoma. We first calculated the age-standardized rate (ASR) of melanoma within PGS tertiles, and then measured the association between skin examination and melanoma detection by calculating the hazard ratio (HR) and 95% confidence interval (95% CI), overall and within PGS tertiles. RESULTS: Melanoma incidence increased with PGS (ASR per 100 000 per year): tertile 1 = 442; tertile 2 = 519; tertile 3 = 871. We found that the HRs for all melanomas (i.e. in situ and invasive) associated with skin examination differed slightly across PGS tertiles [age- and sex-adjusted tertile 1 HR 1.88 (95% CI 1.26-2.81); tertile 2 HR 1.70 (95% CI 1.20-2.41); tertile 3 HR 1.96 (95% CI 1.43-2.70); fully adjusted tertile 1 HR 1.14 (95% CI 0.74-1.75); tertile 2 HR 1.21 (95% CI 0.82-1.78); tertile 3 HR 1.41 (95% CI 1.00-1.98)], but these differences were not statistically significant. HRs for in situ melanoma associated with skin examination were similar across PGS tertiles. For invasive melanomas, the point estimates appeared to be highest in PGS tertile 3 in both the minimally adjusted (age, sex) and fully adjusted models; however, these apparent differences were also not statistically significant. CONCLUSIONS: Genetic risk predicts subsequent melanoma incidence, and is weakly associated with screening behaviour, but it does not explain the higher rate of melanoma detection between screened and unscreened people.
引用
- Pandeya N, Dusingize JC, Olsen CM, et al. Does genetic risk modify the effect of skin screening on melanoma detection rates? Br J Dermatol. 2023. PMID: 37681503. doi:10.1093/bjd/ljad333
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。